RenovoRx

RNXT • NASDAQ • Stock Fundamentals

RenovoRx is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shaun R. Bagai, with a market cap of $41.3M.

Market Cap$41.3M

Employees8.0

CEOShaun R. Bagai

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about RenovoRx

RenovoRx (RNXT) has a market capitalization of $41.3M and trades on NASDAQ.

RenovoRx has approximately 8 employees.